Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Publication
Article
Pharmacy Practice in Focus: Health Systems
March 2019Volume8 Issue 2
Improving the Performance of Specialty Pharmacists in the Care of Patients With Pulmonary Arterial Hypertension
Author(s):
FACULTY:
James S. Kalus, PharmD, FASHP Director of Pharmacy Henry Ford Health System Detroit, Michigan
EDUCATIONAL OBJECTIVES:
At the completion of this activity, the participant will be able to:
- Analyze the unaddressed gaps of reversal agents for direct oral anticoagulants (DOACs) and the risk of bleeding complications
- Identify patients hwho are at high risk for major bleeding secondary to DOAC use
- Examine current and emerging DOAC reversal agents and their safety and efficacy
- Explore the role of the health-system pharmacist in ensuring optimal management of the patient with DOAC-associated bleeding and implementing standards of practice for reversal agents using clinical vignetttes.
TARGET AUDIENCE: Health-system pharmacists
ACTIVITY TYPE: Application
RELEASE DATE: March 15, 2019
EXPIRATION DATE: March 15, 2020
ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours
FEE: This lesson is offered for free at www.pharmacytimes.org.
Articles in this issue
Use AUC to Optimize Vancomycin Dosing
Approach Respiratory Illnesses Rationally
Manage Acute Pain in Those Using Opioids
Documenting 340B Value Is Key to Success
Panelists Discuss Challenges of Diagnosing HE
News and Trends March 2019
Perform an AOR to Comply With USP
Enterprise Collaborations Help Meet Challenges
Cancer Pain Treatment Remains a Challenge
Here Is What to Know About Vaccines for Seniors
RA Treatment Strategies Can Keep the Pain at Bay
The Health-System Pharmacist Role in Optimizing Outcomes for Patients Who Need DOAC Reversal Agents
Drug Price Increases: Here We Go Again?
Helping Patients Breathe Easier
Improving the Performance of Specialty Pharmacists in the Care of Patients With Pulmonary Arterial Hypertension
Related Content
